Here are the states set to ban or severely limit abortion access now that Roe v. Wade is overturned

Here are the states set to ban or severely limit abortion access now that Roe v. Wade is overturned


The overturning of the landmark Roe v. Wade ruling by the Supreme Court is set to almost immediately remake how access to abortion looks in America, with nearly half of the states on track to outright ban or severely limit the procedure.

Twenty-two states had laws or constitutional amendments that were already in place which could be quickly used to try to ban abortion as a result of the decision, according to the Guttmacher Institute, a leading reproductive rights advocacy group.

The laws include bans on abortion that were already in place in a number of states before the Supreme Court with its 1973 decision in Roe ruled that there was a constitutional right to abortion.

Other states have so-called trigger laws that would ban abortion in the event that Roe was overturned by the high court.

And a dozen states would ban abortion after six weeks, which abortion-rights advocates argue is effectively a ban on the procedure, as most people are unaware they are pregnant by that time.



Source

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here
Health

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here

Wall Street is optimistic that Olema Pharmaceutical could be developing the next major breakthrough breast cancer treatment. Earlier this month, the company announced promising clinical data for its lead candidate palazestrant, an oral medication that is being evaluated in several trials for estrogen receptor-positive, or ER+, breast cancer. Shares of the clinical-stage biopharmaceutical company are up […]

Read More
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’
Health

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’

It’s been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for rheumatology and oncology — as well as potential new drugs in the pipeline. The stock has jumped about 50% in just the last three months, earning it a spot on CNBC’s list of top performing […]

Read More
We’re raising our Eli Lilly price target — what a difference a quarter makes
Health

We’re raising our Eli Lilly price target — what a difference a quarter makes

Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications. The company also raised its full-year sales outlook for the second time in a row, inspiring confidence in the trajectory of the franchise. Revenue in the three months ended Sept. 30 jumped 54% year […]

Read More